CDEK
← All organizations

Neos Therapeutics, Inc

For profitWebsite ↗

Also known as: NEOS THERAP INC | NEOS THERAPS | NEOS THERAPS INC

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Jul 1, 2013

First marketed drug

Jun 29, 2012

Last known activity

Jul 1, 2013

Acquired by AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience on Dec 10, 1966

Timeline

1960s

  1. Dec 10, 1966

    AYTU BioScience— Acquired By

  2. Dec 10, 1966

    AYTU BioScience— Now

2000s

  1. Jun 1, 2008

    Neos Therapeutics, Inc— Founded

2010s

  1. Jun 29, 2012

    hydrocodone— Marketing Organization

  2. Jun 19, 2017

    methylphenidate— NDA Secondary Org

2020s

  1. Feb 10, 2021

    AYTU BioScience— Acquired

Drugs by trial phase (2 distinct, 2 trials)

Phase 3 (0 own, 2 via acquisition)

Indications

Studied for

Marketed drugs (4)

Subsidiaries (1 direct, 25 total across the full acquisition tree)

Recent trials (1)

Details

Founded
Grand Prairie, TX, US Jun 1, 2008
Last known activity
Jul 1, 2013